Search hospitals > Wisconsin > Stevens Point

Marshfield Medical Center-River Region at Stevens Point

Claim this profile
Stevens Point, Wisconsin 54482
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
254 reported clinical trials
24 medical researchers
Photo of Marshfield Medical Center-River Region at Stevens Point in Stevens PointPhoto of Marshfield Medical Center-River Region at Stevens Point in Stevens PointPhoto of Marshfield Medical Center-River Region at Stevens Point in Stevens Point

Summary

Marshfield Medical Center-River Region at Stevens Point is a medical facility located in Stevens Point, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Marshfield Medical Center-River Region at Stevens Point is involved with conducting 254 clinical trials across 412 conditions. There are 24 research doctors associated with this hospital, such as Seth O. Fagbemi, Adedayo A. Onitilo, Chady A. Leon, MD, and Demet Gokalp Yasar.

Area of expertise

1Cancer
Global Leader
Marshfield Medical Center-River Region at Stevens Point has run 101 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Marshfield Medical Center-River Region at Stevens Point has run 41 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 negative
ER positive

Top PIs

Clinical Trials running at Marshfield Medical Center-River Region at Stevens Point

Breast Cancer
Cancer
Prostate Cancer
Lung Cancer
Pancreatic Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Multiple Myeloma
Urothelial Carcinoma
Anal Cancer
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Hormone Therapy with or without Radiation

for Breast Cancer

This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Image of trial facility.

Support Program

for Breast Cancer

This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Marshfield Medical Center-River Region at Stevens Point?
Marshfield Medical Center-River Region at Stevens Point is a medical facility located in Stevens Point, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Marshfield Medical Center-River Region at Stevens Point is involved with conducting 254 clinical trials across 412 conditions. There are 24 research doctors associated with this hospital, such as Seth O. Fagbemi, Adedayo A. Onitilo, Chady A. Leon, MD, and Demet Gokalp Yasar.